Eaton Vance Management’s Tandem Diabetes Care TNDM Stock Holding History

Eaton Vance Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$26.9M	Sell	561,500 -135,466	-19%	-$7.43M	0.04%	380
2022 Q2	$41.3M	Buy	696,966 +407,148	+140%	+$33.4M	0.06%	314
2022 Q1	$33.7M	Buy	289,818 +26,569	+10%	+$3.1M	0.04%	389
2021 Q4	$39.6M	Sell	263,249 -175,781	-40%	-$23.7M	0.05%	342
2021 Q3	$52.4M	Sell	439,030 -88,553	-17%	-$9.76M	0.07%	254
2021 Q2	$51.4M	Buy	527,583 +70,583	+15%	+$6.29M	0.07%	270
2021 Q1	$40.3M	Buy	457,000 +114,474	+33%	+$10.6M	0.06%	305
2020 Q4	$32.8M	Buy	342,526 +63,496	+23%	+$6.54M	0.05%	328
2020 Q3	$31.7M	Buy	279,030 +22,735	+9%	+$2.39M	0.06%	282
2020 Q2	$25.4M	Buy	+256,295	New	+$20.5M	0.05%	299

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eaton Vance Management's TNDM Position: Q3 2022 in Review

Eaton Vance Management reduced its Tandem Diabetes Care (TNDM) stake by 19% in Q3 2022, selling an estimated $7.43M and leaving 561,500 shares worth $26.9M. The position accounts for 0.04% of the portfolio, ranked #380.

Eaton Vance Management first reported a position in TNDM in Q2 2020 and has held it in 10 quarters since. The position peaked at $52.4M in Q3 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

Eaton Vance Management held 561,500 shares of Tandem Diabetes Care worth $26.9M as of Q3 2022.
Eaton Vance Management sold 135,466 Tandem Diabetes Care shares in Q3 2022, an estimated $7.43M.
Tandem Diabetes Care made up 0.04% of Eaton Vance Management's portfolio in Q3 2022, its #380 holding.
Eaton Vance Management first reported a position in Tandem Diabetes Care in Q2 2020 and has held it in 10 quarters since.
Eaton Vance Management's Tandem Diabetes Care position peaked at $52.4M in Q3 2021.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.